Accueil   Agenda - News   Toutes les news Adocia announces two new multi-hormonal combination projects

Adocia announces two new multi-hormonal combination projects

Adocia announces two new multi-hormonal combination projects for the treatment of type 1 diabetes

 

  • BioChaperone® enables combinations of insulin lispro with pramlintide and insulin lispro with exenatide, three hormones approved for the treatment of diabetes.
  • Medical benefit of such combinations already established in type 1 diabetes clinical trials with separate injections.
  • New projects aim to offer more efficient therapy to people living with type 1 diabetes without increasing number of injections.
  • First clinical study expected to start in Q4 2017.

 

Voir le communiqué de presse